Pharmaceutical companies are under fire again for their role in the national opioid abuse epidemic, and this time, it could be criminal. Federal prosecutors have opened a criminal probe to determine if pharmaceutical companies intentionally allowed the flow of opioid drugs, The Wall Street Journal reported.